Targeting the Gαi1/3–Gab1 Axis Enhances BMP2-Mediated Bone Regeneration

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Bone morphogenetic protein 2 (BMP2) is a pivotal cytokine for skeletal formation, homeostasis, and regeneration. While its signaling through serine/threonine kinase receptors (BMPRI/II) and downstream pathways (PI3K-Akt-mTOR, Erk, Smad) is known to drive osteogenesis, the full mechanistic picture remains incomplete. Our prior work identified Gαi1 and Gαi3, inhibitory G protein alpha subunits, as key mediators for several receptor tyrosine kinase (RTK) signaling pathways. Their potential role in BMP2 signaling and bone formation, however, was undefined. Methods We employed a multi-modal approach combining clinical observation, genetic mouse models, and molecular/cellular techniques. Bone marrow mesenchymal stem cells (BMSCs) from young and elderly subjects, as well as from wild-type (WT) and Gαi1/3 double knockout (DKO) mice, were analyzed. In vitro , BMP2-induced signaling and osteogenic differentiation were assessed in BMSCs, MC3T3-E1 osteoblasts, and mouse embryonic fibroblasts (MEFs) following genetic manipulation (knockout, knockdown, overexpression) of Gαi1/3. In vivo effects were evaluated in Gαi1/3 DKO mice and a femoral fracture model using mice with BMSC-specific Gαi1/3 knockdown (Gαi1/3-CKD), treated with or without BMP2. Mechanistic studies involved co-immunoprecipitation, molecular docking, and analysis of the adaptor protein Gab1. Results Gαi1/3 expression was reduced in bone tissue and BMSCs from aged/osteoporotic subjects and mice. Gαi1/3 DKO mice exhibited delayed skeletal development, reduced bone mass, and impaired bone formation. In vitro , genetic ablation of Gαi1/3, but not Gαi2, abolished BMP2-induced activation of downstream Akt, Erk, and Smad pathways in MEFs, MC3T3-E1 cells, and BMSCs, and severely blunted BMP2-stimulated osteogenic differentiation and mineralization. Conversely, Gαi1/3 overexpression enhanced these effects. In the fracture model, BMP2 failed to promote healing in Gαi1/3-CKD mice. Mechanistically, Gαi1/3 were essential for BMP2-induced phosphorylation of the scaffolding protein Gab1. Gαi1/3 physically associated with BMP2 receptors (BMPR1A/B, BMPR2) and Gab1, facilitating this complex formation. Disrupting this interaction via dominant-negative Gαi1/3 mutants impaired downstream signaling and osteogenesis. Conclusions Our findings establish the Gαi1/3-Gab1 signaling axis as a critical and novel component of BMP2 receptor (serine/threonine kinase) signal transduction, essential for BMP2-induced osteogenesis both in vitro and in vivo . This work expands the functional repertoire of Gαi proteins beyond GPCRs and RTKs and identifies Gαi1/3 as potential therapeutic targets for enhancing bone formation and treating bone disorders like fractures and osteoporosis.

Article activity feed